What is the diagnosis for a patient who develops shortness of breath and fever during a blood transfusion, with a hemoglobin (Hb) level of 70 g/L?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnosis: Febrile Non-Hemolytic Transfusion Reaction (FNHTR)

The patient most likely has a febrile non-hemolytic transfusion reaction (FNHTR), which is the most common transfusion reaction, occurring in 1.1-2.15% of transfusions and typically presenting with isolated fever and mild symptoms during or shortly after transfusion. 1

Clinical Reasoning

Timing and Presentation Analysis

The key diagnostic features in this case are:

  • Fever and shortness of breath developing 2 hours after transfusion initiation - This timing is critical for differential diagnosis 2
  • Hemoglobin of 70 g/L - Indicates severe anemia but stable enough that the patient survived to develop symptoms 1
  • Absence of hypotension or hemodynamic instability - This is crucial in ruling out more serious reactions 3

Why FNHTR is Most Likely

FNHTR presents with fever occurring within 1-6 hours of transfusion, often accompanied by mild dyspnea, and represents a benign, self-limited reaction. 1, 2 The fever rate with prestorage leukoreduction is 1.1%, and 2.15% with poststorage leukoreduction 1. This patient's presentation at 2 hours post-transfusion with fever and dyspnea, without mention of severe hypoxemia, hypotension, or pulmonary edema, fits this diagnosis perfectly.

Excluding Other Diagnoses

TRALI (Option D) is excluded because:

  • TRALI presents with severe hypoxemia, bilateral pulmonary infiltrates, and acute respiratory distress within 1-2 hours, not just "shortness of breath" 3, 4
  • TRALI requires non-cardiogenic pulmonary edema and represents a life-threatening emergency with fluid in the endotracheal tube 3
  • The question describes dyspnea but does not mention severe hypoxemia, bilateral infiltrates, or respiratory failure that characterizes TRALI 5, 6

Allergic reaction (Option A) is excluded because:

  • Allergic reactions typically present with urticaria, pruritus, and skin manifestations, not primarily fever and dyspnea 3

Anaphylactic reaction (Option B) is excluded because:

  • Anaphylaxis presents with severe hypotension, bronchospasm, angioedema, and cardiovascular collapse within minutes 3
  • The patient's presentation lacks these life-threatening features

Critical Clinical Distinctions

Fever occurring during or immediately after transfusion (within minutes to 2 hours) with hypotension or hemodynamic instability suggests serious reactions requiring immediate intervention, such as acute hemolytic reaction or bacterial contamination. 2 This patient lacks these features.

TACO can develop during transfusion or up to 12 hours afterward, presenting with respiratory distress, pulmonary edema, cardiovascular changes, and potentially fever. 3 However, TACO is now the most common cause of transfusion-related mortality and would present with clear signs of fluid overload, which are not described here 3.

Management Implications

For FNHTR, the appropriate management includes:

  • Stop the transfusion immediately and maintain IV access 3
  • Administer antipyretics (this is appropriate for FNHTR but contraindicated in more serious reactions until they are excluded) 3
  • Monitor vital signs closely 3
  • Rule out more serious reactions before attributing symptoms to FNHTR 2

Key Clinical Pitfall

Do not dismiss fever as "just FNHTR" without excluding life-threatening causes, particularly bacterial contamination and acute hemolytic reactions. 2 However, given the clinical presentation described—fever and dyspnea at 2 hours without hemodynamic instability, severe hypoxemia, or pulmonary edema—FNHTR remains the most likely diagnosis among the options provided.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Timeframe for Post-Transfusion Fever Presentation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Transfusion-Related Complications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Transfusion-related acute lung injury (TRALI)].

Pneumologie (Stuttgart, Germany), 2014

Research

Transfusion-related acute lung injury.

Transfusion medicine reviews, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.